248 related articles for article (PubMed ID: 33831430)
1. Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.
Wang B; Zhong JL; Li HZ; Wu B; Sun DF; Jiang N; Shang J; Chen YF; Xu XH; Lu HD
Life Sci; 2021 Jul; 277():119452. PubMed ID: 33831430
[TBL] [Abstract][Full Text] [Related]
2.
Qiu D; Hu J; Hu J; Yu A; Othmane B; He T; Ding J; Cheng X; Ren W; Tan X; Yu Q; Chen J; Zu X
Front Immunol; 2021; 12():705086. PubMed ID: 34777336
[TBL] [Abstract][Full Text] [Related]
3.
Sharad S; Dobi A; Srivastava S; Srinivasan A; Li H
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32842649
[TBL] [Abstract][Full Text] [Related]
4. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
[TBL] [Abstract][Full Text] [Related]
5. PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.
Li J; Kong WM
J Immunol Res; 2022; 2022():4510462. PubMed ID: 35497877
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.
Sharad S; Ravindranath L; Haffner MC; Li H; Yan W; Sesterhenn IA; Chen Y; Ali A; Srinivasan A; McLeod DG; Yegnasubramanian S; Srivastava S; Dobi A; Petrovics G
Epigenetics; 2014 Jun; 9(6):918-27. PubMed ID: 24694733
[TBL] [Abstract][Full Text] [Related]
7. Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.
Li H; Mohamed AA; Sharad S; Umeda E; Song Y; Young D; Petrovics G; McLeod DG; Sesterhenn IA; Sreenath T; Dobi A; Srivastava S
Oncotarget; 2015 Jun; 6(17):15137-49. PubMed ID: 25883222
[TBL] [Abstract][Full Text] [Related]
8. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
Luo C; Chen J; Chen L
Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
10. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.
Xu LL; Shanmugam N; Segawa T; Sesterhenn IA; McLeod DG; Moul JW; Srivastava S
Genomics; 2000 Jun; 66(3):257-63. PubMed ID: 10873380
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
12. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of PMEPA1 in gastric cancer.
Wen F; Yang S; Cai W; Zhao M; Qin L; Jiao Z
Mol Cell Probes; 2023 Dec; 72():101931. PubMed ID: 37683830
[TBL] [Abstract][Full Text] [Related]
14. PMEPA1 facilitates non-small cell lung cancer progression via activating the JNK signaling pathway.
Tan B; Chen Y; Xia L; Yu X; Peng Y; Zhang X; Yang Z
Cancer Biomark; 2021; 31(3):203-210. PubMed ID: 33896822
[TBL] [Abstract][Full Text] [Related]
15. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
[TBL] [Abstract][Full Text] [Related]
16. A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer.
Richter E; Masuda K; Cook C; Ehrich M; Tadese AY; Li H; Owusu A; Srivastava S; Dobi A
Epigenetics; 2007; 2(2):100-9. PubMed ID: 18174752
[TBL] [Abstract][Full Text] [Related]
17. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
[TBL] [Abstract][Full Text] [Related]
19. The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.
Fournier PG; Juárez P; Jiang G; Clines GA; Niewolna M; Kim HS; Walton HW; Peng XH; Liu Y; Mohammad KS; Wells CD; Chirgwin JM; Guise TA
Cancer Cell; 2015 Jun; 27(6):809-21. PubMed ID: 25982816
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of Frizzled 2 in different cancer types.
Zhou M; Sun X; Zhu Y
FEBS Open Bio; 2021 Apr; 11(4):1195-1208. PubMed ID: 33565732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]